Advertisement
Screener

ATOSSA THERAPEUTICS, INC. (ATOS) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

ATOSSA THERAPEUTICS, INC. Operating Cash Flow

ATOSSA THERAPEUTICS, INC. (ATOS) reported Operating Cash Flow of -$19.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07

  • ATOSSA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.64M.
  • ATOSSA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$9.58M.
  • ATOSSA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$10.54M.
  • ATOSSA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.00M.
  • ATOSSA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$29.76M.
  • ATOSSA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$21.03M.
  • ATOSSA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$20.94M.
  • ATOSSA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$20.76M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filedNet Cash Provided by (Used in) Operating Activities 41 monthNet Cash Provided by (Used in) Operating Activities 44 monthNet Cash Provided by (Used in) Operating Activities 47 monthNet Cash Provided by (Used in) Operating Activities 50 monthNet Cash Provided by (Used in) Operating Activities 53 month
2026-06-30-$9.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$19.23M
10-Q · filed 2026-08-07
-$29.76M
derived: sum of 3 quarters · filed 2026-08-07
-$35.77M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$9.58M
10-Q · filed 2026-05-08
-$20.12M
derived: sum of 2 quarters · filed 2026-05-08
-$26.13M
derived: sum of 3 quarters · filed 2026-05-08
-$33.38M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$10.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$16.54M
derived: sum of 2 quarters · filed 2026-03-25
-$23.80M
derived: sum of 3 quarters · filed 2026-08-07
-$29.76M
10-K · filed 2026-03-25
2025-09-30-$6.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$13.26M
derived: sum of 2 quarters · filed 2026-08-07
-$19.22M
10-Q · filed 2025-11-12
-$26.27M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$7.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$13.22M
10-Q · filed 2026-08-07
-$20.27M
derived: sum of 3 quarters · filed 2026-08-07
-$25.02M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$5.96M
10-Q · filed 2026-05-08
-$13.01M
derived: sum of 2 quarters · filed 2026-05-08
-$17.76M
derived: sum of 3 quarters · filed 2026-05-08
-$22.29M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$7.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$11.80M
derived: sum of 2 quarters · filed 2026-03-25
-$16.33M
derived: sum of 3 quarters · filed 2026-03-25
-$21.03M
10-K · filed 2026-03-25
2024-09-30-$4.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$9.28M
derived: sum of 2 quarters · filed 2025-11-12
-$13.98M
10-Q · filed 2025-11-12
-$19.55M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$4.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$9.23M
10-Q · filed 2025-08-12
-$14.80M
derived: sum of 3 quarters · filed 2025-08-12
-$18.68M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$4.70M
10-Q · filed 2025-05-13
-$10.27M
derived: sum of 2 quarters · filed 2025-05-13
-$14.15M
derived: sum of 3 quarters · filed 2025-05-13
-$18.62M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$5.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25
-$9.45M
derived: sum of 2 quarters · filed 2025-03-25
-$13.92M
derived: sum of 3 quarters · filed 2025-03-25
-$20.94M
10-K · filed 2025-03-25
2023-09-30-$3.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$8.35M
derived: sum of 2 quarters · filed 2024-11-12
-$15.37M
10-Q · filed 2024-11-12
-$19.89M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$4.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
-$11.49M
10-Q · filed 2024-08-12
-$16.01M
derived: sum of 3 quarters · filed 2024-08-12
-$21.42M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$7.02M
10-Q · filed 2024-05-13
-$11.54M
derived: sum of 2 quarters · filed 2024-05-13
-$16.95M
derived: sum of 3 quarters · filed 2024-05-13
-$22.90M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$4.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$9.93M
derived: sum of 2 quarters · filed 2024-04-01
-$15.88M
derived: sum of 3 quarters · filed 2024-04-01
-$20.76M
10-K · filed 2024-04-01
2022-09-30-$5.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$11.36M
derived: sum of 2 quarters · filed 2023-11-13
-$16.24M
10-Q · filed 2023-11-13
-$19.90M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$5.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$10.83M
10-Q · filed 2023-08-14
-$14.49M
derived: sum of 3 quarters · filed 2023-08-14
-$17.55M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$4.88M
10-Q · filed 2023-05-15
-$8.54M
derived: sum of 2 quarters · filed 2023-05-15
-$11.61M
derived: sum of 3 quarters · filed 2023-05-15
-$16.94M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$3.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
-$6.73M
derived: sum of 2 quarters · filed 2023-03-22
-$12.06M
derived: sum of 3 quarters · filed 2023-03-22
-$16.47M
10-K · filed 2023-03-22
2021-09-30-$3.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$8.40M
derived: sum of 2 quarters · filed 2022-11-07
-$12.81M
10-Q · filed 2022-11-07
-$12.81M
10-Q · filed 2021-11-15
-$16.24M
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30-$5.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$9.74M
10-Q · filed 2022-08-08
-$9.75M
10-Q · filed 2021-08-13
-$13.18M
derived: sum of 3 quarters · filed 2022-08-08
-$15.86M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31-$4.41M
10-Q · filed 2022-05-09
-$4.41M
10-Q · filed 2021-05-14
-$7.84M
derived: sum of 2 quarters · filed 2022-05-09
-$10.52M
derived: sum of 3 quarters · filed 2022-05-09
-$12.75M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31-$3.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$6.11M
derived: sum of 2 quarters · filed 2022-02-28
-$8.34M
derived: sum of 3 quarters · filed 2022-02-28
-$11.57M
10-K · filed 2022-02-28
-$11.57M
10-K · filed 2021-03-31
2020-09-30-$2.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$4.91M
derived: sum of 2 quarters · filed 2021-11-15
-$8.14M
10-Q · filed 2021-11-15
-$10.85M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$2.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
-$5.46M
10-Q · filed 2021-08-13
-$8.17M
derived: sum of 3 quarters · filed 2021-08-13
-$9.94M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31-$3.23M
10-Q · filed 2021-05-14
-$5.94M
derived: sum of 2 quarters · filed 2021-05-14
-$7.71M
derived: sum of 3 quarters · filed 2021-05-14
-$10.21M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$2.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$4.48M
derived: sum of 2 quarters · filed 2021-03-31
-$6.98M
derived: sum of 3 quarters · filed 2021-03-31
-$9.13M
10-K · filed 2021-03-31
2019-09-30-$1.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
-$4.27M
derived: sum of 2 quarters · filed 2020-11-13
-$6.42M
10-Q · filed 2020-11-13
-$8.86M
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30-$2.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
-$4.65M
10-Q · filed 2020-08-13
-$7.09M
derived: sum of 3 quarters · filed 2020-08-13
-$9.39M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31-$2.15M
10-Q · filed 2020-05-13
-$4.59M
derived: sum of 2 quarters · filed 2020-05-13
-$6.89M
derived: sum of 3 quarters · filed 2020-05-13
-$8.72M
derived: sum of 4 quarters · filed 2020-05-13
2018-12-31-$2.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
-$4.74M
derived: sum of 2 quarters · filed 2020-03-26
-$6.57M
derived: sum of 3 quarters · filed 2020-03-26
-$8.96M
10-K · filed 2020-03-26
2018-09-30-$2.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
-$4.13M
derived: sum of 2 quarters · filed 2019-11-13
-$6.52M
10-Q · filed 2019-11-13
-$8.20M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30-$1.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
-$4.22M
10-Q · filed 2019-08-13
-$5.90M
derived: sum of 3 quarters · filed 2019-08-13
-$7.60M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31-$2.39M
10-Q · filed 2019-05-13
-$4.07M
derived: sum of 2 quarters · filed 2019-05-13
-$5.77M
derived: sum of 3 quarters · filed 2019-05-13
-$7.12M
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31-$1.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28
-$3.38M
derived: sum of 2 quarters · filed 2019-03-28
-$4.73M
derived: sum of 3 quarters · filed 2019-03-28
-$6.59M
10-K · filed 2019-03-28
2017-09-30-$1.70M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14
-$3.05M
derived: sum of 2 quarters · filed 2018-11-14
-$4.91M
10-Q · filed 2018-11-14
-$6.27M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$1.35M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-11-13
-$3.21M
10-Q/A · filed 2018-11-13
$3.20M
10-Q · filed 2017-08-14
-$4.57M
derived: sum of 3 quarters · filed 2018-11-13
-$3.93M
derived: sum of 4 quarters · filed 2018-11-13
2017-03-31-$1.86M
10-Q · filed 2018-05-14
$1.90M
10-Q · filed 2017-05-11
-$3.22M
derived: sum of 2 quarters · filed 2018-05-14
-$2.58M
derived: sum of 3 quarters · filed 2018-05-14
-$4.24M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31-$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
-$720.53K
derived: sum of 2 quarters · filed 2018-03-08
-$2.38M
derived: sum of 3 quarters · filed 2018-03-08
-$5.37M
10-K · filed 2018-03-08
2016-09-30$635.50K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2017-11-13
-$1.02M
derived: sum of 2 quarters · filed 2017-11-13
-$4.02M
10-Q · filed 2017-11-13
-$7.97M
derived: sum of 4 quarters · filed 2017-11-13
2016-06-30-$1.66M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-03-21
-$4.65M
10-Q/A · filed 2017-03-21
-$8.61M
derived: sum of 3 quarters · filed 2017-03-21
-$12.09M
derived: sum of 4 quarters · filed 2017-03-21
2016-03-31-$2.99M
10-Q/A · filed 2017-03-21
-$6.95M
derived: sum of 2 quarters · filed 2017-03-21
-$10.43M
derived: sum of 3 quarters · filed 2017-03-21
-$13.95M
derived: sum of 4 quarters · filed 2017-03-21
2015-12-31-$3.95M
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21
-$7.43M
derived: sum of 2 quarters · filed 2017-03-21
-$10.95M
derived: sum of 3 quarters · filed 2017-03-21
-$13.95M
10-K/A · filed 2017-03-21
2015-09-30-$3.48M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21
-$7.00M
derived: sum of 2 quarters · filed 2017-03-21
-$10.00M
10-Q/A · filed 2017-03-21
2015-06-30-$3.52M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-03-21
-$6.52M
10-Q/A · filed 2017-03-21
2015-03-31-$3.00M
10-Q/A · filed 2017-03-21
2014-12-31-$10.56M
10-K · filed 2016-03-30
2013-09-30-$2.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$4.85M
derived: sum of 2 quarters · filed 2013-11-12
-$6.18M
10-Q · filed 2013-11-12
-$8.11M
derived: sum of 4 quarters · filed 2013-11-12
-$14.01M
10-Q · filed 2013-11-12
2013-06-30-$2.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$3.44M
10-Q · filed 2013-08-14
-$5.38M
derived: sum of 3 quarters · filed 2013-08-14
-$5.53M
derived: sum of 4 quarters · filed 2013-11-12
-$11.27M
10-Q · filed 2013-08-14
2013-03-31-$1.33M
10-Q · filed 2013-05-15
-$3.27M
derived: sum of 2 quarters · filed 2013-05-15
-$3.42M
derived: sum of 3 quarters · filed 2013-11-12
-$4.23M
derived: sum of 4 quarters · filed 2013-11-12
-$9.16M
10-Q · filed 2013-05-15
2012-12-31-$1.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
-$2.08M
derived: sum of 2 quarters · filed 2013-11-12
-$2.89M
derived: sum of 3 quarters · filed 2013-11-12
-$3.90M
10-K · filed 2013-03-28
-$7.83M
10-K · filed 2013-03-28
2012-09-30-$150.98K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$962.48K
derived: sum of 2 quarters · filed 2013-11-12
-$1.97M
10-Q · filed 2013-11-12
-$3.01M
derived: sum of 4 quarters · filed 2013-11-12
-$5.89M
10-Q/A · filed 2013-01-22
2012-06-30-$811.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$1.82M
10-Q · filed 2013-08-14
-$2.86M
derived: sum of 3 quarters · filed 2013-08-14
2012-03-31-$1.01M
10-Q · filed 2013-05-15
-$2.04M
derived: sum of 2 quarters · filed 2013-05-15
2011-12-31-$1.04M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28
-$3.49M
10-K · filed 2013-03-28
2011-09-30-$2.45M
10-Q/A · filed 2013-01-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
Rocket One Inc. (RKTO)United States$0.019B
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
NextCure, Inc. (NXTC)United States$0.024B-0.15
Biofrontera Inc. (BFRI)United States$0.018B-2.13